-
Introducing the 2026 CRI Lloyd J. Old STARs: Five Scientists Shaping the Future of Cancer Immunotherapy
The Cancer Research Institute (CRI) is proud to announce the 2026 class of Lloyd J. Old STARs… -
Why You Should Leave CRI in Your Will
Including CRI in your will is a personal and meaningful way to create a world immune to… -
Cancer Research Institute Announces 2026 Recipients of Highest Scientific Honors in Cancer Immunotherapy
The Cancer Research Institute (CRI) is proud to announce the recipients of its 2026 Scientific Achievement Awards:… -
Seeing the Miraculous in the Mundane: “I Get To…”
Pick up the kids. Go grocery shopping. Go to work. Throw a birthday party. Make dinner. Run errands. These are just… -
Cancer Clinical Trials: What Patients Should Know
If you or a loved one has been diagnosed with cancer, you’ve likely heard the term “clinical… -
Noodling the Impact of AI on the Immunotherapy Landscape at Cancer Progress 2026
At Lumanity’s Cancer Progress 2026, the goal wasn’t just to showcase innovation — it was to pressure-test… -
A Lifesaving Legacy and Enduring Commitment to Research: The Landesman Family
Each year, a community gathers with a shared purpose: to honor a life lost too soon and… -
Make Every Dollar Count: Maximize Deduction, Multiply Impact with CRI
Supporters are reaching out, seeking to understand the combined impact of changes to federal funding for cancer… -
Remembering Dr. Malcolm A.S. Moore, A Visionary Who Helped Change the Course of Cancer Treatment
The Cancer Research Institute (CRI) mourns the loss of Malcolm A.S. Moore, DPhil, who passed on September…
